Publikation: Using protease inhibitors in antigen presentation assays
Lade...
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2013
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Beitrag zu einem Sammelband
Publikationsstatus
Published
Erschienen in
VAN ENDERT, Peter, ed.. Antigen Processing. Totowa, NJ: Humana Press, 2013, pp. 31-39. Methods in Molecular Biology. 960. ISBN 978-1-62703-217-9. Available under: doi: 10.1007/978-1-62703-218-6_3
Zusammenfassung
The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) lumenal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Protease, Proteasome, Inhibiton, Antigen presentation, Antigen processing, MHC-I surface staining, lacZ assay, T cell hybridomas, Intracellular cytokine staining, T cell lines
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
BASLER, Michael, Marcus GRÖTTRUP, 2013. Using protease inhibitors in antigen presentation assays. In: VAN ENDERT, Peter, ed.. Antigen Processing. Totowa, NJ: Humana Press, 2013, pp. 31-39. Methods in Molecular Biology. 960. ISBN 978-1-62703-217-9. Available under: doi: 10.1007/978-1-62703-218-6_3BibTex
@incollection{Basler2013Using-21985, year={2013}, doi={10.1007/978-1-62703-218-6_3}, title={Using protease inhibitors in antigen presentation assays}, number={960}, isbn={978-1-62703-217-9}, publisher={Humana Press}, address={Totowa, NJ}, series={Methods in Molecular Biology}, booktitle={Antigen Processing}, pages={31--39}, editor={van Endert, Peter}, author={Basler, Michael and Gröttrup, Marcus} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/21985"> <dcterms:issued>2013</dcterms:issued> <dc:contributor>Gröttrup, Marcus</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:title>Using protease inhibitors in antigen presentation assays</dcterms:title> <dcterms:bibliographicCitation>Antigen Processing : Methods and Protocols / ed. by Peter van Endert. - Totowa, NJ : Humana Press, 2012. - S. 31-39. - (Methods in Molecular Biology ; 960). - ISBN 978-1-627-03217-9</dcterms:bibliographicCitation> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/21985"/> <dc:creator>Gröttrup, Marcus</dc:creator> <dc:contributor>Basler, Michael</dc:contributor> <dcterms:abstract xml:lang="eng">The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) lumenal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.</dcterms:abstract> <dc:language>eng</dc:language> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-02-26T11:10:04Z</dcterms:available> <dc:rights>terms-of-use</dc:rights> <dc:creator>Basler, Michael</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-02-26T11:10:04Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> </rdf:Description> </rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja